Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Research question: what are the patterns of patient-reported changes in physical function
among adult patients using SC abatacept with moderate to severe RA since commencement of the
compassionate use program (CUP).